Uveal Melanoma: all 281 studies
Page 1 of 3. Open to participants first (50), then studies with results posted, then the rest; newest registration first within each.
- High-precision Radiosurgery Followed by Minimally Invasive Surgical Approach in Patients With High-prominence Uveal Melanoma: Modern Radiation Techniques and OutcomesRecruitingNCT07913412
- Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET Protein on TumorsNot yet recruitingNCT07863024Phase 1/2
- Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal MelanomaRecruitingNCT07804186Phase 3
- Study of Neoadjuvant RBP-01 In Patients With Primary Uveal MelanomaNot yet recruitingNCT07747935Phase 1/2
- A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid TumorsRecruitingNCT07636785Phase 1/2
- Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced MelanomaRecruitingNCT07627698Phase 1/2
- Neoadjuvant Immunotherapy for Patients With High-risk Eye MelanomaRecruitingNCT07501117Phase 1
- Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the LiverRecruitingNCT07364474Not applicable
- A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal MelanomaEnrolling by invitationNCT07338968
- Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal MelanomaRecruitingNCT07276386Phase 2
- Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell HomeostasisRecruitingNCT07203391Phase 1
- Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic MelanomaNot yet recruitingNCT07183852Phase 1
- Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal MelanomaRecruitingNCT07136181Phase 1/2
- Adding IL-2 to Tebentafusp to Eradicate Cancer ProgressionRecruitingNCT07063875Phase 1/2
- Neoadjuvant Darovasertib in Primary Uveal MelanomaRecruitingNCT07015190Phase 3
- Resistance Exercise in Patients With Ocular MelanomaRecruitingNCT06970236Not applicable
- Clinical Trial of CD40L-augmented TIL for Patients With Advanced MelanomaRecruitingNCT06961357Phase 1/2
- A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive LifileucelRecruitingNCT06940739Phase 1/2
- Adjuvant Quisinostat in High-Risk Uveal MelanomaRecruitingNCT06932757Phase 2
- A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-KitRecruitingNCT06805825Phase 1
- Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal MelanomaRecruitingNCT06627244Phase 2
- Tebentafusp-tebn With LDT in Metastatic UMRecruitingNCT06626516Phase 1/2
- A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal MelanomaRecruitingNCT06581406Phase 2/3
- Identification of New Candidate Genes for Hereditary Predisposition to Uveal MelanomaRecruitingNCT06550674Not applicable
- PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver MetastasesRecruitingNCT06519266Phase 3
- Neoadjuvant Tebentafusp for Uveal MelanomaRecruitingNCT06414590Phase 2
- Uveal Melanoma - Comparative StudyRecruitingNCT06284512
- Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal MelanomaRecruitingNCT06280040
- Adjuvant Tebentafusp in High Risk Ocular MelanomaRecruitingNCT06246149Phase 3
- Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal MelanomaRecruitingNCT06121180Phase 2
- Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method StudyNot yet recruitingNCT06073548
- Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal MelanomaRecruitingNCT06070012Phase 2
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.RecruitingNCT06022029Phase 1
- Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver MetastasesNot yet recruitingNCT05903937Phase 1
- Melphalan Chemoreduction for Ocular MelanomaEnrolling by invitationNCT05893654Phase 1/2
- Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal MelanomaRecruitingNCT05889481
- Retrospective Register for Uveal MelanomaRecruitingNCT05733728
- A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or AngiosarcomaRecruitingNCT05607095Phase 1
- Adjuvant Melatonin for Uveal MelanomaRecruitingNCT05502900Phase 3
- Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical PracticeRecruitingNCT05402059
- A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal MelanomaRecruitingNCT05077280Phase 2
- A Cohort IND Expanded Access Program for Supporting Patient Access to TebentafuspAvailableNCT04960891
- Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid TumoursRecruitingNCT04855435Phase 1
- Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition SyndromeRecruitingNCT04792463
- MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck CancerRecruitingNCT04729543Phase 1/2
- Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)RecruitingNCT04424719Not applicable
- Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsRecruitingNCT04119024Phase 1
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsRecruitingNCT03947385Phase 1/2
- ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsRecruitingNCT03686124Phase 1/2
- Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal MelanomaRecruitingNCT01438658
- Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal MelanomaTerminatedNCT05308901Phase 2Results posted
- KZR-261 in Subjects With Advanced Solid MalignanciesTerminatedNCT05047536Phase 1Results posted
- A Study of SEA-CD40 Given With Other Drugs in CancersCompletedNCT04993677Phase 2Results posted
- Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal MelanomaTerminatedNCT04720417Phase 2Results posted
- Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal MelanomaTerminatedNCT04589832Phase 1/2Results posted
- Nivolumab Plus Relatlimab in Patients With Metastatic Uveal MelanomaCompletedNCT04552223Phase 2Results posted
- Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal MelanomaTerminatedNCT03712904Phase 2Results posted
- Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the LiverCompletedNCT03472586Phase 2Results posted
- A Phase II Study of BVD-523 in Metastatic Uveal MelanomaTerminatedNCT03417739Phase 2Results posted
- A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)CompletedNCT03207347Phase 2Results posted
- Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal MelanomaCompletedNCT03070392Phase 2Results posted
- Study in Subjects With Small Primary Choroidal MelanomaCompletedNCT03052127Phase 1/2Results posted
- IMCgp100-401 Rollover StudyTerminatedNCT02889861Phase 2Results posted
- Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain MetastasesCompletedNCT02858869Phase 1Results posted
- Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal MelanomaTerminatedNCT02831933Phase 2Results posted
- Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal MelanomaCompletedNCT02771340Phase 1Results posted
- Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal MelanomaTerminatedNCT02743611Phase 1/2Results posted
- Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular MelanomaCompletedNCT02678572Phase 3Results posted
- A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal MelanomaCompletedNCT02570308Phase 1/2Results posted
- Neoadjuvant and Adjuvant Checkpoint BlockadeCompletedNCT02519322Phase 2Results posted
- Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal MelanomaCompletedNCT02363283Phase 2Results posted
- Pembrolizumab in Treating Patients With Advanced Uveal MelanomaTerminatedNCT02359851Phase 2Results posted
- Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver MetastasesTerminatedNCT02336763Not applicableResults posted
- Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566CompletedNCT02315066Phase 1Results posted
- Crizotinib in High-Risk Uveal Melanoma Following Definitive TherapyCompletedNCT02223819Phase 2Results posted
- Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT02158520Phase 2Results posted
- A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV MelanomaCompletedNCT02129075Phase 2Results posted
- Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By SurgeryCompletedNCT01989572Phase 3Results posted
- Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal MelanomaActive, not recruitingNCT01979523Phase 2Results posted
- Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)CompletedNCT01974752Phase 3Results posted
- Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV MelanomaCompletedNCT01961115Phase 2Results posted
- Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by SurgeryCompletedNCT01835145Phase 2Results posted
- Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular MelanomaTerminatedNCT01814046Phase 2Results posted
- A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal MelanomaTerminatedNCT01801358Phase 1/2Results posted
- Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal MelanomaCompletedNCT01585194Phase 2Results posted
- Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by SurgeryTerminatedNCT01533948Phase 2Results posted
- SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to LiverCompletedNCT01473004Phase 2Results posted
- Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal MelanomaTerminatedNCT01471054Phase 2Results posted
- Cixutumumab in Treating Patients With Metastatic Melanoma of the EyeCompletedNCT01413191Phase 2Results posted
- RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal MelanomaCompletedNCT01252251Phase 2Results posted
- Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)CompletedNCT01251978Phase 2Results posted
- Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal MelanomaTerminatedNCT01200342Phase 2Results posted
- STA-9090(Ganetespib) in Metastatic Ocular MelanomaCompletedNCT01200238Phase 2Results posted
- Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the EyeCompletedNCT01143402Phase 2Results posted
- Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic ImbalanceCompletedNCT01100528Phase 2Results posted
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By SurgeryCompletedNCT00738361Phase 2Results posted
- Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal MelanomaCompletedNCT00680225Phase 3Results posted
- Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSFCompletedNCT00661622Phase 2Results posted
- Treatment With Intravitreal Avastin for Large Uveal MelanomasCompletedNCT00596362Not applicableResults posted
- Safety and Efficacy of Marqibo in Metastatic Malignant Uveal MelanomaCompletedNCT00506142Phase 2Results posted